Inhibition of PDGF receptor signaling sensitizes cells to anti-VEGF/VEGFR treatment, suggesting a possible route of resistance and a potential therapeutic target in anti-VEGFR melanoma therapy [181]. This evidence concerns the gene KDR and melanoma.